Abstract:Background: Latent tuberculosis infection (LTBI) is the primary source of active tuberculosis (ATB), but there are no specific methods for diagnosing and preventing LTBI. Methods: Dominant T and B cell epitopes predicted from five antigens related to LTBI and Mycobacterium tuberculosis region of difference (LTBI-RD) were used to construct a novel polypeptide molecule (PPM). Then, the physicochemical properties, secondary structure, tertiary structure of the PPM, and its binding ability to toll-like receptor 2 (TLR2) and TLR4 were analyzed by bioinformatics tools. Finally, immune stimulation and expression optimization of the PPM were carried out. Results: Four helper T lymphocytes (HTL) epitopes, five cytotoxic T lymphocytes (CTL) epitopes, and three B cell epitopes were predicted and screened from five LTBI-RD related antigens. These epitopes were connected in series with linkers and adjuvants to construct a novel PPM termed C543P. The results indicated that antigenicity and immunogenicity scores of the C543P candidate were 0.936399 and 1.36469, respectively. The structural analysis results showed that the C543P candidate had good stability. Its secondary structure contained 43.6% α-helix, the Z-score after tertiary structure optimization was −7.9, and the Ramachandran diagram showed that 88.77% amino acid residues of the C543P candidate were in the allowable region. Furthermore, the C543P candidate showed an excellent affinity to TLR2 (−1091.7kcal/mol) and TLR4 (−1102.7kcal/mol). In addition, we also analyzed the immunological characteristics of the C543P candidate. Immune stimulation prediction showed that the C543P candidate could effectively activate T and B lymphocytes and produce high levels of Th1 cytokines such as IFN-γ and IL-2. Conclusion: We constructed a novel PPM with acceptable antigenicity, immunogenicity, stability, and ability to induce robust immune responses. This study provides a new diagnostic biomarker or peptides-based vaccine for LTBI diagnosis and prevention.

The prediction of T-and B-combined epitope of Ag 85 B antigen of Mycobacterium tuberculosis

Prediction and Identification of HLA-A*0201 Restricted CD8+CTL Epitope in Mycobacterium Tuberculosis Ag85C

Prediction and analysis of the distribution of T cell epitopes encoded by the specific RD12 region of Mycobacterium tuberculosis

Analysis of predicted CD8 + T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis

Analysis of Predicted T Cell Epitopes from Proteins Encoded by the Specific RD1 Region of Mycobacterium tuberculosis

In Silico Identification of Cytotoxic T Lymphocyte Epitopes Encoded by RD5 Region of Mycobacterium Tuberculosis.

Prediction and Identification of HLA-A* 0201 Restricted CTL Epitopes in Mycobacteriun Tuberculosis Rv0173

[Construction and Immunogenicity of DNA Vaccine Encoding Secreted Form of Ag85B Protein of Mycobacterium Tuberculosis].

CLONING AND EXPRESSION OF MYCOBACTERIUM TUBERCULOSIS Ag85B IN E. COLI

Epitope Prediction of Rv3873 Gene from Mycobacterium Tuberculosis and Antigenicity Analysis of Related Protein Fragments

Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals.

Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis

Analysis of the Antigenic Properties of Membrane Proteins of Mycobacterium Tuberculosis

In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis

In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis

In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection

Immunogenicity and Protective Efficacy of Ag85A and Truncation of PstS1 Fusion Protein Vaccines Against Tuberculosis

Investigation of Immunogenicity of Ag85A Recombinant Fusion Protein from Mycobacterium Tuberculosis

[Mycobacterium Tuberculosis Secreting Protein Ag85B-ESAT6 Fused Expression and Purification].

Investigation into Immunogenicity of Multiepitope Polypeptide from Mycobacterium Tuberculosis

Novel insights into Mycobacterium antigen Ag85 biology and implications in countermeasures for M. tuberculosis.